Latest filing published 30 Sept 2026 for Mineralys Therapeutics, Inc., €1.7M. Read the official filing
All filings by Congleton Jon on record concern Mineralys Therapeutics, Inc. The record holds 3 filings, for trades running from 30 June 2026 to 30 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 30 September 2026 came the latest disclosure, a transaction for €1.7M in Mineralys Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations